These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32811502)

  • 21. A new core-shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma.
    Xie MH; Fu ZL; Hua AL; Zhou JF; Chen Q; Li JB; Yao S; Cai XJ; Ge M; Zhou L; Wu J
    Front Oncol; 2022; 12():932156. PubMed ID: 36185205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
    Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
    Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination and pharmacokinetic study of the diacid metabolite of norcantharidin in beagle plasma by use of liquid chromatography-tandem mass spectrometry.
    Liu M; Ma X; Jin Z; Li W; Guo M; Li F
    Anal Bioanal Chem; 2013 Nov; 405(28):9273-83. PubMed ID: 24096565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
    Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
    Fan F; Sun XF
    Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
    Jiang Z; Chi J; Han B; Liu W
    Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
    Ding Z; Xu B; Zhang H; Wang Z; Sun L; Tang M; Ding M; Zhang T; Shi S
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically relevant interactions of anti-apoptotic Bcl-2 protein inhibitors with ABC transporters.
    Ruzickova E; Janska R; Dolezel P; Mlejnek P
    Pharmazie; 2017 Dec; 72(12):751-758. PubMed ID: 29441961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
    Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
    Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
    J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro.
    Qiao-ling Z; Yi Z; Min G; Di-jia Y; Xiao-feng Z; Yang L; Jing-yu X; Ying W; Zong-lin G; Kong-lang X; Ai-jun Z; Wei-liang C; Lin-sen S; Xue-nong Z; Qiang Z
    Curr Med Chem; 2012; 19(33):5754-63. PubMed ID: 22963621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma.
    Zhang H; Jiang Y; Ni X; Chen L; Wu M; Liu J; Yang B; Shan X; Yang L; Fan J; Chen Y; Wu J; Fu S
    J Biomed Nanotechnol; 2018 Jan; 14(1):114-126. PubMed ID: 29463369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
    High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
    Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
    Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
    Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the liver targeting of norcantharindin microemulsion].
    Zhang L; Xiang D; Hong Z; Zhang ZR
    Yao Xue Xue Bao; 2004 Aug; 39(8):650-5. PubMed ID: 15563071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.